NCT05040295View on ClinicalTrials.gov

A Single Dose Study To Test Two Pediatric Forms Of Ritlecitinib Compared With Adult Ritlecitinib In Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 10, 2021

Primary Completion Date

November 19, 2021

Study Completion Date

November 19, 2021

Conditions
Healthy Participants
Interventions
DRUG

ritlecitinib

30 mg intact adult capsule

DRUG

ritlecitinib

10 mg pediatric capsule

DRUG

ritlecitinib

30 mg spray congealed beads

Trial Locations (1)

06511

New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05040295 - A Single Dose Study To Test Two Pediatric Forms Of Ritlecitinib Compared With Adult Ritlecitinib In Healthy Adults | Biotech Hunter | Biotech Hunter